A
Abderrahim Lomri
Researcher at French Institute of Health and Medical Research
Publications - 47
Citations - 2728
Abderrahim Lomri is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Osteoblast & Osteocalcin. The author has an hindex of 28, co-authored 47 publications receiving 2643 citations.
Papers
More filters
Journal ArticleDOI
Reactive oxygen species and superoxide dismutases: role in joint diseases.
TL;DR: In this paper, the role of superoxide dismutases (SODs) and their derivates as mediators of inflammation was discussed and new knowledge about the role and role of the superoxide anion and its derivates was discussed.
Journal Article
Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.
TL;DR: The results show that activating mutation of Gs alpha in osteoblastic cells leads to constitutive activation of adenylate cyclase, increased cell proliferation, and inappropriate cell differentiation, resulting in overproduction of a disorganized fibrotic bone matrix in polyostotic and monostotic fibrous dysplasia.
Journal ArticleDOI
Bone morphogenetic protein-2 and transforming growth factor-β2 interact to modulate human bone marrow stromal cell proliferation and differentiation
TL;DR: Analysis of the effects and interactions of local factors on HBMS cell proliferation and differentiation in short‐term and long‐term cultures suggests that TGF‐β2 and BMP‐2 may act in a sequential manner at different stages to promote human bone marrow stromal cell differentiation towards the osteoblast phenotype.
Journal ArticleDOI
Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces
TL;DR: It is shown that the bone cell populations isolated from trabecular bone surface are enriched in osteoblast precursors and mature osteoblstic cells.
Journal ArticleDOI
Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody.
TL;DR: Clonal F/STRO‐1+ A cells immunoselected from human fetal BM stroma display features of immature osteoprogenitor cells which can differentiate into mature osteogenic cells by cell–cell interactions or inducing agents.